In the multicentre, randomized CHOICE-01 study, #Toripalimab with chemotherapy was investigated as first-line treatment in treatment-naïve patients with advanced #NSCLC...

In multicenter, phase 3 #MITNEC-A1 study, 18F-sodium fluoride PET–CT was compared to 99mTc bone scintigraphy with SPECT in patients with...

#Margetuximab failed to improve OS in patients with pretreated HER2- positive metastatic #breast_cancer in the final overall survival analysis of...

In multicenter, phase 3 #MITNEC-A1 study, 18F-sodium fluoride PET–CT was compared to 99mTc bone scintigraphy with SPECT in patients with...

In the prospective, randomized ENGOT/GCIG study by AGO s, GINECO, NSGO study groups, standard duration of #bevacizumab (15 months) treatment...

A systematic review and meta-analysis of 33 studies that included 4,330 #breast_cancer patients and was done to compare effectiveness of...

In the multicenter, phase II SALV-ENZA trial, 86 men with biochemically recurrent #prostate_cancer after RP were randomized to either...

An individualized breast cancer risk assessment model for women attending screening in BreastScreen Norway. The large retrospective cohort study included...

Secondary analysis of phase III N107C/CEC.3 trial was conducted to compare whole-brain radiotherapy [WBRT] or stereotactic radiosurgery [SRS]) regarding quality...

In COSMIC-313 trial presented by Dr. Toni Choueiri, #cabozantinib (C) in combination with #nivolumab (N) and #ipilimumab (I) improved PFS...